Willbe is affiliated with all the business domains in Alive
WillbeWillbeWillbe
info@willbe.com
Tokyo, Japan
WillbeWillbeWillbe

About Project

Willbe is affiliated with all the business domains in Alive! Network which include media operation, brand development, e-commerce, wholesale and farm operation.
The Company will issue two separate tokens for use on the platform:
  • WillBeCoin – WBC
  • WillBeToken – WBT
  • WillBe users will be able to use their standard WBC tokens to pay for fees, for staking,for trading fee discounts, and for buying different features in the future when they are released.WBC will be the token distributed by the Company through the sales in the exchange or wallet .
    Business Model & Supporters
    Advertising revenue in the form of programmatic, direct display and pre-roll from endemic and national brands
    Licensing our brand IP (shows, logo, etc. ) to value adding networks and national brands
    Sponsorship revenue in the form of programmatic, direct display and pre-roll from endemic and national brands
    Direct to consumer events driving ticketing, merch and sponsorship revenue
    A hemp e-commerce store for Alive! and curated strategic partner products.
    → First original brand name “Willbe” with Vape and Gumi
    → Strategic partner product “Ignite”
    https://ignite.co
    https://www.instagram.com/danbilzerian

    Project Willbe

    Marketplace

    SupplyChain

    Distribution

    Cultivation

    Franchise

    Far far away, behind the word mountains, far from the and Consonantia, there live the blinds and Separated they live in Bookmarksgrove language ocean. A small river named Duden flows.

    Market

    The global cannabidiol (CBD) market has been estimated to reach USD 2,740 million in 2021 and is projected to grow at a CAGR of around 51% during the forecast period till 2030. The demand for CBD-based products is growing due to their healing properties for various health conditions and medical disorders. Heart diseases, cancer, anxiety, depression, pain relief, and inflammation are some health conditions that can be potentially treated using cannabidiol products. Cannabidiol (CBD) is one of the 113 cannabinoids identified in the cannabis plant. The CBD-based products include oil, dried cannabis, capsules, and liquid solution. The products can be consumed in multiple ways like inhaling smoke or vapor and eating.
    Government regulations also support CBD market growth. For instance, the U.S. Food and Drug Administration (FDA) has approved some of the purified forms of CBD products and concluded the benefits of CBD drug to be safe and effective. The growing clinical trials, research & development investments, and legalization of CBD in other parts of the globe can open new opportunities and further assist the cannabidiol (CBD) market growth.

    Significant Market Developments Considered in the Report:

    In March 2021, Greenheart CBD, an Irish company has become the first CBD company to offer decentralized finance token. The token will help the company to expand and offer cost-effective products to its token holders.

    In November 2020, the Court of Justice of the European Union (CJEU) ruled that CBD is not narcotic and does not have any psychotropic effects on human health.




    In October 2020, the Dental College of Georgia and Medical College of Georgia demonstrated the ability of CBD to reduce inflammation and physical lung damage and improve oxygen levels related to adult respiratory distress syndrome.

    In June 2020, a biopharmaceutical company, Greater Cannabis Company Inc. announced the completion of the development, manufacturing, and shipment of 125,000 units of first order of oral CBD patch.